-
The Pitfalls and Promise of Using Repurposed Drugs for COVID-19
27 May 2021 23:20 GMT
… drugs, including statins, antivirals, and rheumatoid arthritis medications … and Drug Administration (FDA) as potential treatments for … hopes the antidepressant fluvoxamine, the antiparasitic drug ivermectin, … pharmaceutical industry and the Food and Drug …
-
Glenmark Pharma gets USFDA nod for generic drug
19 Oct 2020 07:14 GMT
… from the US Food and Drug Administration (USFDA) for the … CV's Rapamune tablets, Glenmark Pharmaceuticals said in a statement … either alone or with other medications.
According to IQVIA sales … and has 45 abbreviated new drug applications (ANDAs) pending with …
-
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg
19 Oct 2020 04:20 GMT
… States Food & Drug Administration (U.S. FDA) for Sirolimus Tablets, … mg, the generic version of Rapamune®1 Tablets, 0.5 … period ending August 2020, the Rapamune® Tablets, 0.5 mg, … and portfolio.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in …
-
Global Rapamune (Sirolimus) Market 2020 Industry Emerging Trend, Market Players, Revenue Insights to 2026
17 Jul 2020 02:43 GMT
…
Cardinal Health
Zydus Pharmaceuticals
Cadila Pharnmaceuticals
Greenstone, Llc
...
Rapamune (Sirolimus) Breakdown … 2020)
11.3.4 Zydus Pharmaceuticals Rapamune (Sirolimus) Products Offered
11.3 … Files Dispatch
Contact Us:
QYResearch Medical
URL - http:/…
-
Drugs for heartburn, gout and depression now being tested as coronavirus treatments
02 May 2020 15:10 GMT
… care.
Regeneron Pharmaceuticals Inc. will test its drug sarilumab (Kevzara) … return to normal after treatment with tocilizumab, 15 … trials, Montefiore Medical Center in New York will test the drug … (Luvox) is an antidepressant used mainly to treat obsessive …
-
Global Mechanistic Target of Rapamycin (mTOR) Inhibitors Market Astonishing Growth | Top Competitors like Novartis AG, Accord Healthcare, Hikma Pharmaceuticals PLC, Par Pharmaceuticals
03 Mar 2020 08:12 GMT
… , Hikma Pharmaceuticals PLC, Par Pharmaceuticals, Teva Pharmaceuticals Industries Ltd … product launch, clinical trials pipelines, product approvals, … treatment and stringent FDA guidelines for the drug … market includes afinitor, rapamune, torisel, zortress, and …
-
Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer
09 May 2018 14:53 GMT
… treatment for prostate cancer, and hope to begin a clinical trial … sirolimus (Rapamune), which is used for organ transplants. That drug, … permit the biotech to run smaller clinical trials with fewer … uses of the active pharmaceutical ingredient and how long …
-
Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures
11 Apr 2018 00:16 GMT
… US Food and Drug Administration (FDA) has approved … doctor experienced with the disorder to ensure that tumor … (ACE) inhibitor medicine during treatment with Afinitor or … Pharmaceuticals Corporation; April 2018. 3. ASCO CancerNet.com https://www.cancer …
-
Global $200 Billion Opportunity for Nanoparticle Drug Delivery Market by 2024 - Size, Current Trends, and Dynamics
20 Apr 2018 15:38 GMT
… increasing demand for effective treatment methods to provide for … of Cancer
4. Importance of Nanoparticle Drug Delivery in Cancer Therapy
… liposomal)
8.4 Sirolimus (Rapamune)
8.4.1 Availability, … 15.2 Access Pharmaceuticals
15.3 Alnylam Pharmaceuticals
15.4 …
-
US$ 200 Billion Opportunity: Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2024
20 Apr 2018 07:10 GMT
… demand for effective treatment methods to provide for … Drug: 231 Drugs
Drugs In & Above Phase II Trials: 33 Drugs
Marketed Nanoparticle Drugs: 13 Drugs …
8.4 Sirolimus (Rapamune)
8.4.1 Availability … 2 Access Pharmaceuticals
15.3 Alnylam Pharmaceuticals
15.4 …
About
© 1995-2021